Supreme Court Considering Taking on Gene Patents Case
The Supreme Court of the United States on Friday began considering whether to take up the case between Myriad Genetics, the Association of American Pathology, and other plaintiffs ...

With the availability of the full sequence of the human genome and those of now hundreds of other organisms, there are enormous opportunities and expectations for utilizing these sequences – and the knowledge and understanding that comes from them – to benefit the public welfare. At the same time, the rapidly increasing pace of discovery in genome sciences and the prospect of widespread use of genomic information has raised awareness of a number of potentially troubling issues for society at large, in areas as diverse as individual rights, genetic discrimination, privacy, race and gender issues, the nature of humanity, personal responsibility, intellectual property law, and national health and science policy.
This has never been clearer than it is today, as rapidly advancing and ever-cheaper technologies have made whole-genome sequencing all but routine and truly personal genomics is here. With those advances, the questions the science raises for society have only grown deeper and more urgent. IGSP investigators are exploring these intersections between genomes and society and what they mean or might mean in the context of our personal and social lives, our health and health care, our legal and regulatory systems and our very identities.
The IGSP also houses the Center for Public Genomics (CpG), a Center of Excellence in Ethical, Legal, and Social Implications (ELSI) Research co-funded by the Department of Energy and the NIH. CpG was established to explore the value of "open science" norms and practices as well as to study the benefits and risks of intellectual property protections in genomics through historical, legal, economic and empirical research.
The Supreme Court of the United States on Friday began considering whether to take up the case between Myriad Genetics, the Association of American Pathology, and other plaintiffs ...
It could be that we are on the verge of a great deluge of cognitive enhancement. Or it’s possible that new brain-enhancing drugs and technologies will be nothing compared to ...
Bob Cook-Deegan is a signatory on an amicus brief in support of petitioners challenging the patent eligibility of isolated DNA and urging the high court to take the case against ...
Nobel Prize winner Sir John Sulston and Dr. Robert Waterston delivered a lecture on the social value of science and the free spread of scientific data. Their talk, “The Common ...
In Personalized Medicine, Misha Angrist argues in favor of full disclosure of genetic and other 'omic' data as a means to engage participants in science and the research ...
In Science, a group of HHMI Professors, including Hunt Willard, discuss a report recommending that scientific competencies replace course requirements for medical school ...
Charmaine Royal is co-author of a study in the Journal of Community Genetics aimed to examine the implementation and effectiveness of community education workshops to change ...
In Genetic Testing and Molecular Biomarkers, Susanne Haga finds that focus group participants welcomed the integration of PGx testing into therapeutic decision-making.
© 2004-2012, Duke Institute for Genome Sciences & Policy. Duke University | Duke Medicine | Interdisciplinary Studies at Duke